Product NDC: | 47584-001 |
Proprietary Name: | Fludeoxyglucose |
Non Proprietary Name: | Fludeoxyglucose F18 |
Active Ingredient(s): | 500 mCi/mL & nbsp; Fludeoxyglucose F18 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47584-001 |
Labeler Name: | Cyclotron Partners LP dba Cyclotope |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA203665 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111208 |
Package NDC: | 47584-001-01 |
Package Description: | 16 mL in 1 VIAL, GLASS (47584-001-01) |
NDC Code | 47584-001-01 |
Proprietary Name | Fludeoxyglucose |
Package Description | 16 mL in 1 VIAL, GLASS (47584-001-01) |
Product NDC | 47584-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fludeoxyglucose F18 |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20111208 |
Marketing Category Name | ANDA |
Labeler Name | Cyclotron Partners LP dba Cyclotope |
Substance Name | FLUDEOXYGLUCOSE F-18 |
Strength Number | 500 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |